175 related articles for article (PubMed ID: 32463305)
21. Omega-3 fatty acid treatment, with or without cytidine, fails to show therapeutic properties in bipolar disorder: a double-blind, randomized add-on clinical trial.
Murphy BL; Stoll AL; Harris PQ; Ravichandran C; Babb SM; Carlezon WA; Cohen BM
J Clin Psychopharmacol; 2012 Oct; 32(5):699-703. PubMed ID: 22926607
[TBL] [Abstract][Full Text] [Related]
22. Dietary interventions for multiple sclerosis.
Farinotti M; Vacchi L; Simi S; Di Pietrantonj C; Brait L; Filippini G
Cochrane Database Syst Rev; 2012 Dec; 12():CD004192. PubMed ID: 23235605
[TBL] [Abstract][Full Text] [Related]
23. Impact of Different Doses of Omega-3 Fatty Acids on Cardiovascular Outcomes: a Pairwise and Network Meta-analysis.
Lombardi M; Chiabrando JG; Vescovo GM; Bressi E; Del Buono MG; Carbone S; Koenig RA; Van Tassell BW; Abbate A; Biondi-Zoccai G; Dixon DL
Curr Atheroscler Rep; 2020 Jul; 22(9):45. PubMed ID: 32671519
[TBL] [Abstract][Full Text] [Related]
24. Omega 3 fatty acids and inborn errors of metabolism.
Gil-Campos M; Sanjurjo Crespo P
Br J Nutr; 2012 Jun; 107 Suppl 2():S129-36. PubMed ID: 22591887
[TBL] [Abstract][Full Text] [Related]
25. ω-3 fatty acids therapy for IgA nephropathy: a meta-analysis of randomized controlled trials.
Liu LL; Wang LN
Clin Nephrol; 2012 Feb; 77(2):119-25. PubMed ID: 22257542
[TBL] [Abstract][Full Text] [Related]
26. Omega-3 fatty acids for cystic fibrosis.
Oliver C; Watson H
Cochrane Database Syst Rev; 2013 Nov; (11):CD002201. PubMed ID: 24282091
[TBL] [Abstract][Full Text] [Related]
27. Omega-3 fatty acids as an adjunct for periodontal therapy-a review.
Chee B; Park B; Fitzsimmons T; Coates AM; Bartold PM
Clin Oral Investig; 2016 Jun; 20(5):879-94. PubMed ID: 26885664
[TBL] [Abstract][Full Text] [Related]
28. Effects of Zinc Supplementation on Inflammatory Skin Diseases: A Systematic Review of the Clinical Evidence.
Dhaliwal S; Nguyen M; Vaughn AR; Notay M; Chambers CJ; Sivamani RK
Am J Clin Dermatol; 2020 Feb; 21(1):21-39. PubMed ID: 31745908
[TBL] [Abstract][Full Text] [Related]
29. Omega-3 fatty acids for intermittent claudication.
Sommerfield T; Price J; Hiatt WR
Cochrane Database Syst Rev; 2007 Oct; (4):CD003833. PubMed ID: 17943801
[TBL] [Abstract][Full Text] [Related]
30. Nutraceutical Status and Scientific Strategies for Enhancing Production of Omega-3 Fatty Acids from Microalgae and their Role in Healthcare.
Gupta J; Gupta R
Curr Pharm Biotechnol; 2020; 21(15):1616-1631. PubMed ID: 32619166
[TBL] [Abstract][Full Text] [Related]
31. Role of nutritional supplements in selected dermatological disorders: A review.
Sardana K; Sachdeva S
J Cosmet Dermatol; 2022 Jan; 21(1):85-98. PubMed ID: 34564936
[TBL] [Abstract][Full Text] [Related]
32. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study.
Hobbs T; Caso R; McMahon D; Nymark M
Altern Ther Health Med; 2014; 20(5):18-23. PubMed ID: 25141367
[TBL] [Abstract][Full Text] [Related]
33. Omega-3 fatty acids supplementation for autism spectrum disorders (ASD).
James S; Montgomery P; Williams K
Cochrane Database Syst Rev; 2011 Nov; (11):CD007992. PubMed ID: 22071839
[TBL] [Abstract][Full Text] [Related]
34. A double-blind, placebo-controlled trial of ω-3 fatty acids in Tourette's disorder.
Gabbay V; Babb JS; Klein RG; Panzer AM; Katz Y; Alonso CM; Petkova E; Wang J; Coffey BJ
Pediatrics; 2012 Jun; 129(6):e1493-500. PubMed ID: 22585765
[TBL] [Abstract][Full Text] [Related]
35. Analysis of epidermal lipids in normal and atopic dogs, before and after administration of an oral omega-6/omega-3 fatty acid feed supplement. A pilot study.
Popa I; Pin D; Remoué N; Osta B; Callejon S; Videmont E; Gatto H; Portoukalian J; Haftek M
Vet Res Commun; 2011 Dec; 35(8):501-9. PubMed ID: 21786009
[TBL] [Abstract][Full Text] [Related]
36. Omega-3 fatty acids for cystic fibrosis.
Oliver C; Jahnke N
Cochrane Database Syst Rev; 2011 Aug; (8):CD002201. PubMed ID: 21833942
[TBL] [Abstract][Full Text] [Related]
37. Omega-3 fatty acids (from fish oils) for cystic fibrosis.
McKarney C; Everard M; N'Diaye T
Cochrane Database Syst Rev; 2007 Oct; (4):CD002201. PubMed ID: 17943770
[TBL] [Abstract][Full Text] [Related]
38. Clinical trials with multiple endpoints can establish a correlation, but not (yet) causality, between dietary supplementation with omega-3 fatty acids and keratoconjunctivitis sicca.
Mendoza RL
J Med Econ; 2018 Aug; 21(8):733-744. PubMed ID: 29781353
[TBL] [Abstract][Full Text] [Related]
39. The use of omega-3 fatty acids in mental illness.
Gören JL; Tewksbury AT
J Pharm Pract; 2011 Oct; 24(5):452-71. PubMed ID: 21940602
[TBL] [Abstract][Full Text] [Related]
40. Omega-3 fatty acids for intermittent claudication.
Campbell A; Price J; Hiatt WR
Cochrane Database Syst Rev; 2013 Jul; (7):CD003833. PubMed ID: 23824785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
